Unknown

Dataset Information

Overhauling CAR T Cells to Improve Efficacy, Safety and Cost.


ABSTRACT: Gene therapy is now surpassing 30 years of clinical experience and in that time a variety of approaches has been applied for the treatment of a wide range of pathologies. While the promise of gene therapy was over-stated in the 1990's, the following decades were met with polar extremes between demonstrable success and devastating setbacks. Currently, the field of gene therapy is enjoying the rewards of overcoming the hurdles that come with turning new ideas into safe and reliable treatments, including for cancer. Among these modalities, the modification of T cells with chimeric antigen receptors (CAR-T cells) has met with clear success and holds great promise for the future treatment of cancer. We detail a series of considerations for the improvement of the CAR-T cell approach, including t

SUBMITTER: Chicaybam L 

PROVIDER: S-EPMC7564591 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature